BMS-986020

Investigational

Details

Stereochemistry	ABSOLUTE
Molecular Formula	C29H26N2O5
Molecular Weight	482.5271
Optical Activity	UNSPECIFIED
Defined Stereocenters	1 / 1
E/Z Centers	0
Charge	0

SHOW SMILES / InChI

Structure Search

SMILES

C[C@@H](OC(=O)NC1=C(ON=C1C)C2=CC=C(C=C2)C3=CC=C(C=C3)C4(CC4)C(O)=O)C5=CC=CC=C5

InChI

InChIKey=GQBRZBHEPUQRPL-LJQANCHMSA-N

InChI=1S/C29H26N2O5/c1-18-25(30-28(34)35-19(2)20-6-4-3-5-7-20)26(36-31-18)23-10-8-21(9-11-23)22-12-14-24(15-13-22)29(16-17-29)27(32)33/h3-15,19H,16-17H2,1-2H3,(H,30,34)(H,32,33)/t19-/m1/s1

HIDE SMILES / InChI

Molecular Formula	C29H26N2O5
Molecular Weight	482.5271
Charge	0
Count

Stereochemistry	ABSOLUTE
Additional Stereochemistry	No
Defined Stereocenters	1 / 1
E/Z Centers	0
Optical Activity	UNSPECIFIED

Approval Year

Targets

Primary Target	Pharmacology	Condition	Potency
Lysophosphatidic acid receptor Edg-2 4 Target ID: CHEMBL3819 Sources: https://www.ncbi.nlm.nih.gov/pubmed/25499971	Antagonist 2849		8.9 null [pIC50]

PubMed

Title	Date	PubMed
Randomized, Double-Blind, Placebo-Controlled, Phase 2 Trial of BMS-986020, a Lysophosphatidic Acid Receptor Antagonist for the Treatment of Idiopathic Pulmonary Fibrosis.	2018-11	30201408
Lysophospholipid receptors in drug discovery.	2015-05-01	25499971

Patents

Substance Class	Chemical Created by `admin` on `Mon Mar 31 19:16:42 GMT 2025` Edited by `admin` on `Mon Mar 31 19:16:42 GMT 2025`
Record UNII	38CTP01B4L
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

BMS-986020

Common Name

English

AP-3152 FREE ACID

Preferred Name

English

1-(4'-(3-METHYL-4-(((((R)-1-PHENYLETHYL)OXY)CARBONYL)AMINO)ISOXAZOL-5-YL)BIPHENYL-4-YL)CYCLOPROPANECARBOXYLIC ACID

Systematic Name

English

CYCLOPROPANECARBOXYLIC ACID, 1-(4'-(3-METHYL-4-((((1R)-1-PHENYLETHOXY)CARBONYL)AMINO)-5-ISOXAZOLYL)(1,1'-BIPHENYL)-4-YL)-

Systematic Name

English

Classification Tree Code System Code

FDA ORPHAN DRUG

327810